ACVA (NYSE: ACVA) holder plans 1,750-share common stock sale

Rhea-AI Filing Summary

Andrew Peer, for whose account the securities are to be sold, filed a notice under Rule 144 to sell 1,750 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE. The planned sale has an aggregate market value of 13,982.50, and the number of shares outstanding is 172,171,225.

The shares to be sold were acquired on 12/15/2025 by exercising stock options from the issuer, with 1,750 shares paid for in cash on that date. In the past three months, Rule 10b5-1 sales for Andrew Peer included 1,750 common shares sold on 12/01/2025 for gross proceeds of 14,000.00 and 1,750 common shares sold on 10/15/2025 for gross proceeds of 15,470.00. By signing the notice, the seller represents that he does not know any material adverse information about the issuer that has not been publicly disclosed.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	1750	13982.50	172171225	12/15/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/15/2025	Exercise of Stock Options	Issuer			1750	12/15/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for ANDREW PEER 640 Ellicott Street, #321 Buffalo NY 14203	Common	12/01/2025	1750	14000.00
10b5-1 Sales for ANDREW PEER 640 Ellicott Street, #321 Buffalo NY 14203	Common	10/15/2025	1750	15470.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What planned share sale does the ACVA Form 144 filing disclose?

The notice states that 1,750 shares of common stock are planned to be sold for the account of Andrew Peer through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of 13,982.50.

How were the ACVA shares in the planned sale acquired?

The securities to be sold are 1,750 common shares acquired on 12/15/2025 through the exercise of stock options from the issuer, with payment made in cash on 12/15/2025.

How many ACVA shares has Andrew Peer sold in the past three months?

The filing lists Rule 10b5-1 sales for Andrew Peer of 1,750 common shares on 12/01/2025 for gross proceeds of 14,000.00 and 1,750 common shares on 10/15/2025 for gross proceeds of 15,470.00.

What is the number of ACVA shares outstanding referenced in the Form 144?

The securities information section reports a number of shares or other units outstanding of 172,171,225.

On which exchange are the ACVA shares in this Form 144 expected to trade?

The securities information table identifies the NYSE as the securities exchange for the common shares to be sold.

What representation does the seller make about undisclosed adverse information on ACVA?

The person for whose account the securities are to be sold represents by signing the notice that he does not know any material adverse information regarding the current and prospective operations of the issuer that has not been publicly disclosed.